Cargando…

General anesthesia using propofol infusion for implantation of an implantable cardioverter defibrillator in a pediatric patient with Andersen-Tawil syndrome: a case report

Andersen-Tawil syndrome (ATS) is a rare genetic disease characterized by a triad of episodic flaccid muscle weakness, ventricular arrhythmias, and physical anomalies. ATS patients have various cardiac arrhythmias that can cause sudden death. Implantation of an implantable cardioverter-defibrillator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Seyeon, Heo, Wonjae, Shin, Sang-Wook, Kim, Hye-Jin, Yoo, Yeong Min, Kim, Hee Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Dental Society of Anesthsiology 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911964/ https://www.ncbi.nlm.nih.gov/pubmed/36819605 http://dx.doi.org/10.17245/jdapm.2023.23.1.45

Ejemplares similares

Andersen-Tawil Syndrome
por: Smith, Andrew H, et al.
Publicado: (2006)

Electrocardiogram in Andersen-Tawil Syndrome. New Electrocardiographic Criteria for Diagnosis of Type-1 Andersen-Tawil Syndrome
por: Kukla, Piotr, et al.
Publicado: (2014)

Ventricular Tachyarrhythmias in a Patient with Andersen-Tawil Syndrome
por: Pyo, Jung Yoon, et al.
Publicado: (2013)

Intrapericardial Implantation of an Implantable Cardioverter-Defibrillator in a Child
por: Seong, Yong Won, et al.
Publicado: (2011)

Recurrent syncope in the Andersen Tawil syndrome – Cardiac or neurological?
por: Fryer, Michael David, et al.
Publicado: (2015)

Delayed diagnosed atypical case of Andersen-Tawil syndrome
por: Burakgazi, Ahmet Z.
Publicado: (2019)

Successful cardiac sympathetic denervation for Andersen–Tawil syndrome
por: Krych, Michalina, et al.
Publicado: (2023)

Molecular stratification of arrhythmogenic mechanisms in the Andersen Tawil syndrome
por: Moreno-Manuel, Ana Isabel, et al.
Publicado: (2022)

Andersen–Tawil Syndrome With Novel Mutation in KCNJ2: Case Report
por: Yim, Jisook, et al.
Publicado: (2022)

Tumescent local anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: An alternative for general anesthesia
por: Romero, Jorge, et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Propafenone is not effective for severe ventricular arrhythmias in Andersen-Tawil syndrome
por: Bienias, Piotr, et al.
Publicado: (2016)

Atrial pacing for the management of ventricular arrhythmias in Andersen-Tawil syndrome
por: Fadahunsi, Opeyemi, et al.
Publicado: (2015)

A case report of Andersen-Tawil syndrome misdiagnosed with myodystrophy
por: Zhao, Xiuqin, et al.
Publicado: (2023)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Andersen–Tawil Syndrome and Hypothyroidism: A Case Report with an Unusual Association
por: Saalim, Mohd, et al.
Publicado: (2019)

Case report: Mexiletine suppresses ventricular arrhythmias in Andersen-Tawil syndrome
por: Yang, Jing, et al.
Publicado: (2022)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

The use of implantable cardioverter defibrillators in pediatric patients
por: Campagnucci, V, et al.
Publicado: (2013)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome
por: Le Tanno, Pauline, et al.
Publicado: (2021)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Electrical Storms in Patients with an Implantable Cardioverter Defibrillator
por: Song, Pil Sang, et al.
Publicado: (2011)

Long-Term Prognosis of Patients with an Implantable Cardioverter-Defibrillator in Korea
por: Uhm, Jae-Sun, et al.
Publicado: (2017)

Sanger sequencing as a first-line approach for molecular diagnosis of Andersen-Tawil syndrome
por: Totomoch-Serra, Armando, et al.
Publicado: (2017)

Asymptomatic ventricular tachycardia: diagnostic pitfalls of Andersen–Tawil syndrome—a case report
por: Nguyen, Dustin, et al.
Publicado: (2018)

Flecainide treats a novel KCNJ2 mutation associated with Andersen-Tawil syndrome
por: Van Ert, Hanora A., et al.
Publicado: (2016)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Phenotypic variability in a series of four pediatric patients with Andersen-Tawil syndrome: A Saudi experience
por: Alrashed, Norah A., et al.
Publicado: (2019)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
por: Kommuri, Naga VA, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5qjimk138asjptdimbskmv1dt5